Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
COVID-19 has plateaued in the U.S., but hospitalizations of young adults are up about 40% since early March. And polls suggest some young adults may not be interested in getting vaccinated.
-
For a year, researchers have been studying and arguing over vitamin D's potential for helping protect against or treat COVID-19. The evidence is still not conclusive.
-
Pausing use of the Johnson and Johnson vaccine looks unlikely to cause major problems in the overall U.S. vaccination effort, but some places counting on those doses are scrambling.
-
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs.
-
The Aldaco family of Phoenix suffered more than most in this year of unfathomable losses. Three brothers perished in the pandemic: Jose in July, Heriberto in December and Gonzalo in February.
-
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
-
The country has beat back the winter surge, and experts credit Americans' improved compliance with precautions like mask-wearing. But we could we still face a resurgence if we let up.
-
Glitchy websites, jammed phone lines and long lines outside clinics are complicating the vaccine rollout. And older Americans and those without caregivers and computer skills are at a disadvantage.
-
COVID-19 has now killed more Americans than WWII. That fact helps some people put the viral death toll in perspective, while others find it offensive. Historically, is it even a valid comparison?
-
Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems.